The fact that BCL-6 rearrangements identify biologically and clinically distinct subsets of DLCL suggests that these lesions may be useful as markers in selection of differential therapeutic strategies based on different risk groups .
the fact that bcl-6 rearrangements identify biologically and clinically distinct subsets of dlcl suggests that these lesions may be useful as markers in selection of differential therapeutic strategies based on different risk groups .
O O O B-protein_molecule O O O O O O O O B-other_name O O O O O O O O O O O O O O O O O O O O O